Effect of ketamine intranasal in ease of access to peripheral veins

Effect of ketamine intranasal with placebo in ease of access to peripheral veins and reduce child pain

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120613010017N7

Enrollment

Registered

2018-06-17

Start date

2018-04-24

Completion date

Unknown

Last updated

2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Easy venipuncture in all children that venipuncture is needed in the process of treatment.

Interventions

Intervention 1: Intervention group: Before doing venipuncture, intranasal ketamine will be given with a dose of 4 miligeram per Kilograms body weight and according to the half-life and the maximum eff

Eligibility

Sex/Gender

All

Age

6 Months to 6 Years

Inclusion criteria

Inclusion criteria: Children aged 6 months to 6 years in an emergency needing to venipuncture

Exclusion criteria

Exclusion criteria: Unwell children Intense Dehydration Having a history of allergy to ketamine Seizure Having brain lesions Increased intracranial pressure

Design outcomes

Primary

Measure	Time frame
Success in venipuncture. Timepoint: Count the insert needle. Method of measurement: Count.;Duration in successful venipuncture. Timepoint: Duration from start to end of successful venipuncture. Method of measurement: Observe.	—

Secondary

Measure	Time frame
Patient pain. Timepoint: End of venipuncture. Method of measurement: Using Visual Analogue Scale for pain measurement.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamed Basir Ghafouri

Iran University of Medical Sciences

Basirghafoori.h@iums.ac.ir+98 21 6653 9233

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026